In this session, Irene Ghobrial, MD, discusses efforts to identify precursor conditions to multiple myeloma early and prevent progression to active myeloma. Many screening and treatment clinical trials are available for patients with smoldering multiple myeloma and monoclonal gammopathy of undetermined significance (MGUS). Learn more about the Center for Prevention of Progression. www.dana-farber.org/center-fo...
Негізгі бет Ғылым және технология The PROMISE of Early Detection and Interception in Myeloma
Пікірлер: 3